Pseudolaric Acid C is primarily researched for its potential therapeutic applications, particularly in the field of oncology. Studies have shown that it exhibits significant anti-cancer properties by inducing apoptosis in various cancer cell lines, including those of the liver, lung, and breast. It works by targeting specific signaling pathways that are crucial for cancer cell survival and proliferation. Additionally, it has been explored for its anti-angiogenic effects, which can inhibit the formation of new blood vessels that supply nutrients to tumors, thereby limiting their growth. Beyond cancer, Pseudolaric Acid C is also investigated for its anti-inflammatory and anti-fungal activities, making it a compound of interest in the development of new treatments for inflammatory diseases and fungal infections. Its potential in modulating immune responses further broadens its application scope in immunology research.